Curta is bringing a full team of researchers and thought leaders to ISPOR 2026 in Philadelphia, May 17-20. With six poster presentations, a research podium session, and senior leaders featured across high-profile panels and plenaries, this year’s conference represents one of our largest presences at ISPOR to date.
Our research staff will be presenting original work spanning some of the most pressing topics in health economics and outcomes research. Posters cover areas including the budget impact of emerging oncology therapies, the economic impact of digital health solutions, expanding access to long-acting reversible contraceptives, affordability insights from state all-payer claims databases, and evidence quality in digital health. On Wednesday, our team will take the podium to present new findings on projected Medicare drug price negotiation savings in 2027.
Beyond our research presentations, Curta’s senior leadership will be front and center in some of the conference’s most anticipated sessions. Sean D. Sullivan, PhD, Curta’s President and Senior Partner, will speak on a panel examining value-based pricing and CMS drug price negotiation. Scott Ramsey, MD, PhD, our Chief Medical Officer, will moderate the plenary session “The True Cost of Cancer: Aligning Innovation, Access, and Affordability,” speak on a panel focused on evidence-informed budget impact thresholds, and participate in a forum on real-world evidence in rare cancers.
We are passionate about delivering evidence and analysis to solve the toughest problems in healthcare, and ISPOR is where those conversations happen. Whether you want to discuss a current challenge, explore a potential collaboration, or simply meet the team, we’d love to hear from you. Reach out to schedule a meeting with us in Philadelphia, or stop by our booth during the conference. We look forward to seeing you there!